A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu by PEETHAMBARAM, Prema P, MELISKO, Michelle E, RINN, Kristine J, ALBERTS, Steven R, PROVOST, Nicole M, JONES, Lori A, SIMS, Robert B, LIN, Lisa R. C, FROHLICH, Mark W, PARK, John W

Get full text

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102 by Gralow, Julie R., Barlow, William E., Lew, Danika, Dammann, Kim, Somlo, George, Rinn, Kristine J., Vogel, Stanley J., Wong, Lucas, Livingston, Robert B., Hortobagyi, Gabriel N.

Get full text

Delayed-Type Hypersensitivity Response Is a Predictor of Peripheral Blood T-Cell Immunity after HER-2/neu Peptide Immunization by DISIS, M. L, SCHIFFMAN, K, GOOLEY, T. A, MCNEEL, D. G, RINN, K, KNUTSON, K. L

Get full text

[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow by Mankoff, David A, Dunnwald, Lisa K, Gralow, Julie R, Ellis, Georgiana K, Schubert, Erin K, Charlop, Aaron W, Tseng, Jeffrey, Rinn, Kristine J, Livingston, Robert B

Get full text

Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008) by Greenlee, Heather, Lew, Danika L., Hershman, Dawn L., Newman, Vicky A., Hansen, Lisa, Hartman, Sheri J., Korner, Judith, Shi, Zaixing, Sardo Molmenti, Christine L., Sayegh, Antoine, Fehrenbacher, Lou, Lo, Shelly, Klemp, Jennifer, Rinn, Kristine, Robertson, John M., Unger, Joseph, Gralow, Julie, Albain, Kathy, Krouse, Robert, Fabian, Carol

Get full text

Abstract 5299: Machine learning approach to personalized medicine in breast cancer patients: Development of data-driven, personalized, causal modeling through identification and un... by Kaplan, Henry, Berry, Anna, Rinn, Kristine, Ellis, Erin, Birchfield, George, Wahl, Tanya, Liu, Xiaoyu, Tameishi, Mariko, Beatty, J D., Dawson, Patricia, Mehta, Vivek, Holman, Anna, Atwood, Mary, Alexander, Shlece, Bonham, Candy, Summers, Lauren, Khalil, Iya, Hayete, Boris, Wuest, Diane, Zheng, Wei, Liu, Yuhang, Wang, Xulong, Brown, Thomas David

Get full text

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer by DISIS, Mary L, KNUTSON, Keith L, SCHIFFMAN, Kathy, RINN, Kristine, MCNEEL, Douglas G

Get full text

Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu–overexpressing cancers by Disis, Mary L., Rinn, Kristine, Knutson, Keith L., Davis, Donna, Caron, Dania, dela Rosa, Corazon, Schiffman, Kathy

Get full text

A Phase 1 Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu by Peethambaram, Prema P., Melisko, Michelle E., Rinn, Kristine J., Alberts, Steven R., Provost, Nicole M., Jones, Lori A., Sims, Robert B., Lin, Lisa R.C., Frohlich, Mark W., Park, John W.

Get full text

Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients by SCHIFFMAN, Kathy, RINN, Kristine, DISIS, Mary L

Get full text

Antigen-specific recall urticaria to a peptide-based vaccine by Rinn, Kristine, Schiffman, Kathy, Otero, Henry O., Disis, Mary L.

Get full text